DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Schneeweiss S, Korzenik J, Solomon DH. et al.
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections.
Aliment Pharmacol Ther 2009;
30: 253-264
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.